Status:
COMPLETED
Stroke and Anxiety Reduction
Lead Sponsor:
NYU Langone Health
Conditions:
Acute Stroke
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The purpose of this pilot study is to explore the impact that a structured anxiety reduction intervention program has on patients being discharged to home following an acute stroke in an academic medi...
Eligibility Criteria
Inclusion
- Be diagnosed with an acute stroke
- Able to speak, read and write in English
- Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status.
- Discharged to home
- Internet access including email
- Willingness to participate in an anxiety reduction program
- Length of hospital stay less than 5 days from the initial presentation of stroke symptoms
- Must be medically stable
Exclusion
- Not diagnosed with an acute stroke
- Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants.
- Not discharged to home
- No internet access including email
- Unwilling or unable to participate in an anxiety reduction program
- Cognitively impaired
- Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms
- Not medically stable
Key Trial Info
Start Date :
August 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 23 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06013982
Start Date
August 22 2023
End Date
January 23 2025
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016